Exploring the efficacy and contribution of Dupilumab in asthma management
- PMID: 35397375
- DOI: 10.1016/j.molimm.2022.03.119
Exploring the efficacy and contribution of Dupilumab in asthma management
Abstract
IgG4 monoclonal antibody Dupilumab binds to the alpha chain (IL4R) of both types of the ligand-binding domains (IL4R/ IL13R1; equally IL4 and IL13 specific) of the IL-4 receptor. The current focus on precision medicine techniques to blocking pathways implicated in allergy disorders is crucial to the development of Dupilumab and broadening its therapeutic uses. Our review describes how the IL-4R complexes signaling pathway works, explores the probable mechanisms of Dupilumab activity and addresses its clinical usefulness and safety in asthma. The FDA (Food and Drug Administration) already licences it to treat Alzheimer's disease and moderate-to-severe asthma, and it has shown highly significant results in the management of chronic rhinosinusitis and Eosinophilic esophagitis (EoE). Previous investigations and clinical trials undertaken by various pharmaceutical firms are examined in this review article to assess the existing literature fully. The discovery of Dupilumab and the expanding range of therapeutic uses are pertinent to the current focus on precision medicine methods to blocking asthma-related pathways.
Keywords: Asthma; Dupilumab; IL-13; IL-4; TH2 cells.
Copyright © 2022 Elsevier Ltd. All rights reserved.
Similar articles
-
Mechanisms of Dupilumab.Clin Exp Allergy. 2020 Jan;50(1):5-14. doi: 10.1111/cea.13491. Epub 2019 Sep 30. Clin Exp Allergy. 2020. PMID: 31505066 Free PMC article. Review.
-
Dupilumab: A New Paradigm for the Treatment of Allergic Diseases.J Investig Allergol Clin Immunol. 2018 Jun;28(3):139-150. doi: 10.18176/jiaci.0254. J Investig Allergol Clin Immunol. 2018. PMID: 29939132 Review.
-
Dupilumab to Treat Type 2 Inflammatory Diseases in Children and Adolescents.Paediatr Drugs. 2020 Jun;22(3):295-310. doi: 10.1007/s40272-020-00387-2. Paediatr Drugs. 2020. PMID: 32157553 Review.
-
Dupilumab in the treatment of asthma.Immunotherapy. 2019 Jul;11(10):859-872. doi: 10.2217/imt-2019-0008. Epub 2019 Jun 20. Immunotherapy. 2019. PMID: 31218914 Review.
-
Dupilumab: Basic aspects and applications to allergic diseases.Allergol Int. 2020 Apr;69(2):187-196. doi: 10.1016/j.alit.2020.01.002. Epub 2020 Jan 30. Allergol Int. 2020. PMID: 32007360 Review.
Cited by
-
Younger severe asthma patients with interleukin 4 (CC variant) and dupilumab treatment are more likely to achieve clinical remission.BMC Pulm Med. 2025 Mar 21;25(1):131. doi: 10.1186/s12890-025-03578-0. BMC Pulm Med. 2025. PMID: 40119276 Free PMC article.
-
A Pilot Study of Associations Between the Occurrence of Palpitations and Cytokine Gene Variations in Women Prior to Breast Cancer Surgery.Biol Res Nurs. 2023 Apr;25(2):289-299. doi: 10.1177/10998004221134684. Epub 2022 Oct 18. Biol Res Nurs. 2023. PMID: 36255356 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
